Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Current Leases (2022 - 2026)

Lucid Diagnostics filings provide 4 years of Current Leases readings, the most recent being $893000.0 for Q4 2025.

  • On a quarterly basis, Current Leases rose 4.57% to $893000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $893000.0, a 4.57% increase, with the full-year FY2025 number at $893000.0, up 4.57% from a year prior.
  • Current Leases hit $893000.0 in Q4 2025 for Lucid Diagnostics, up from $878000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $1.1 million in Q3 2023 to a low of $769000.0 in Q1 2022.
  • Median Current Leases over the past 4 years was $874500.0 (2025), compared with a mean of $921000.0.
  • Biggest five-year swings in Current Leases: soared 37.72% in 2023 and later decreased 24.2% in 2024.
  • Lucid Diagnostics' Current Leases stood at $962000.0 in 2022, then rose by 14.97% to $1.1 million in 2023, then decreased by 22.78% to $854000.0 in 2024, then grew by 4.57% to $893000.0 in 2025.
  • The last three reported values for Current Leases were $893000.0 (Q4 2025), $878000.0 (Q3 2025), and $871000.0 (Q2 2025) per Business Quant data.